Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Schizophrenia is a leading cause of global disability. Current pharmacotherapy for the
disease predominantly uses one mechanism—dopamine D2 receptor blockade—but often …
disease predominantly uses one mechanism—dopamine D2 receptor blockade—but often …
Schizophrenia: from neurochemistry to circuits, symptoms and treatments.
OD Howes, BR Bukala, K Beck - Nature reviews. Neurology, 2023 - europepmc.org
Schizophrenia is a leading cause of global disability. Current pharmacotherapy for the
disease predominantly uses one mechanism-dopamine D2 receptor blockade-but often …
disease predominantly uses one mechanism-dopamine D2 receptor blockade-but often …
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
OD Howes, BR Bukala, K Beck - Nature reviews. Neurology - pubmed.ncbi.nlm.nih.gov
Schizophrenia is a leading cause of global disability. Current pharmacotherapy for the
disease predominantly uses one mechanism-dopamine D2 receptor blockade-but often …
disease predominantly uses one mechanism-dopamine D2 receptor blockade-but often …